These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26933628)

  • 21. Bleomycin Polidocanol Foam (BPF) Stability - In Vitro Evidence for the Effectiveness of a Novel Sclerosant for Venous Malformations.
    Sun Y; Gu H; Yang X; Cai R; Shang Y; Hu L; Wang Y; Chen H; Lin X
    Eur J Vasc Endovasc Surg; 2020 Jun; 59(6):1011-1018. PubMed ID: 32063463
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Size of Sclerosing Foams Prepared by Ultrasound, Mechanical Agitation, and the Handmade Tessari Method for Treatment of Varicose Veins.
    Critello CD; Fiorillo AS; Matula TJ
    J Ultrasound Med; 2017 Mar; 36(3):649-658. PubMed ID: 28127790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection.
    Cavezzi A; Tessari L
    Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Digital subtraction angiography-guided percutaneous transcatheter foam sclerotherapy of varicocele: a novel tracking technique.
    Li L; Zeng XQ; Li YH
    AJR Am J Roentgenol; 2009 Oct; 193(4):978-80. PubMed ID: 19770319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stability of foam in sclerotherapy: differences between sodium tetradecyl sulfate and polidocanol and the type of connector used in the double-syringe system technique.
    Rao J; Goldman MP
    Dermatol Surg; 2005 Jan; 31(1):19-22. PubMed ID: 15720090
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium tetradecyl sulphate foam stability prior to injection: factors affecting liquid reformation.
    McMaster S
    Phlebology; 2011 Sep; 26(6):222-6. PubMed ID: 21415426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of sclerotherapy with radio-opaque foam guided by digital subtraction angiography for the treatment of complex venous malformations of the head and neck.
    Chen AW; Liu YR; Li K; Zhang K; Wang T; Liu SH
    Br J Oral Maxillofac Surg; 2015 Nov; 53(9):809-13. PubMed ID: 26113044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transient neurologic event following administration of foam sclerotherapy.
    Malvehy MA; Asbjornsen C
    Phlebology; 2017 Feb; 32(1):66-68. PubMed ID: 26826265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Air contamination in the sclerosing foam for the treatment of varicose veins.
    de Franciscis S; Nobile C; Larosa E; Montemurro R; Serra R
    Phlebology; 2016 Mar; 31(2):96-100. PubMed ID: 25514923
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
    Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
    Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risk of bacteria in foam sclerotherapy: does the condition of the air in outpatient vs. operating rooms make a difference?
    Chen J; Liu YR; Sun YD; Liu C; Zhuo SY; Li K; Wei FC; Liu SH
    Br J Dermatol; 2014 Dec; 171(6):1386-90. PubMed ID: 24807810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of sclerotherapy using polidocanol foam: a controlled clinical trial.
    Alòs J; Carreño P; López JA; Estadella B; Serra-Prat M; Marinel-Lo J
    Eur J Vasc Endovasc Surg; 2006 Jan; 31(1):101-7. PubMed ID: 16226901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polidocanol concentration and time affect the properties of foam used for sclerotherapy.
    VAN Deurzen B; Ceulen RP; Tellings SS; VAN DER Geld C; Nijsten T
    Dermatol Surg; 2011 Oct; 37(10):1448-55. PubMed ID: 21790848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preliminary experience with a new sclerosing foam in the treatment of varicose veins.
    Tessari L; Cavezzi A; Frullini A
    Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluoroscopy-guided foam sclerotherapy with sodium morrhuate for peripheral venous malformations: Preliminary experience.
    Li L; Feng J; Zeng XQ; Li YH
    J Vasc Surg; 2009 Apr; 49(4):961-7. PubMed ID: 19341886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Foam sclerotherapy of venous malformations.
    Bergan J; Cheng V
    Phlebology; 2007; 22(6):299-302. PubMed ID: 18274339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety and effectiveness of transcatheter foam sclerotherapy for testicular varicocele with a fluoroscopic tracing technique.
    Li L; Zeng XQ; Li YH
    J Vasc Interv Radiol; 2010 Jun; 21(6):824-8. PubMed ID: 20434363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An investigation on the influence of glycerin on sclerosant foam stability.
    Peterson JD; Goldman MP
    Phlebology; 2011 Sep; 26(6):232-4. PubMed ID: 21415429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Saphenous ablation: sclerosant or sclerofoam?
    Coleridge Smith P
    Semin Vasc Surg; 2005 Mar; 18(1):19-24. PubMed ID: 15791549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.